EFTA Document EFTA01385051

Net loss per common share applicable to $ (0.60) $ (0.46) $ (2.19) $ (1.40) common stockholders, basic and diluted Weighted-average common shares outstanding, 34,347,593 28,037,349 32,290,972 27,883,244 basic and diluted FOUNDATION MEDICINE, INC. Condensed Consolidated Balance Sheets (In thousands) (unaudited) September 30, December 31, 2015 2014 Assets Current assets: Cash and cash equivalents Accounts receivable, net Inventories 9,460 4,809 Prepaid expenses and other current assets 6,120 Total current assets 275,813 89,648 Property and equipment, net 36,774 21,015 Restricted cash 1,395 864 Other assets 1,026 411 Total assets $ 315,008 $ 111,938 $ 250,162 $ 72,080 10,071 9,894 Liabilities and stockholders' equity Current liabilities: 2,865 Accounts payable $ 11,963 $ 7,263 Accrued expenses and other current 16,069 7,414 liabilities Deferred revenue 455 340 Current portion of deferred rent 2,094 1,429 Total current liabilities 30,581 16,446 Other non-current liabilities 10,953 9,323 Total stockholders' equity 273,474 86,169 Total liabilities and stockholders' equity $ 315,008 $ 111,938 View source version on businesswire.com: http://www.businesswire.cominews/home/20151103006781/en/ Contact: Media Contact: CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0085919 CONFIDENTIAL SDNY_GM_00232103 EFTA01385051